The director of the ALGOS research group and of the Chair in Childhood Pain at the URV is the first Spanish councillor at the IASP, which has been in existence for more than 50 years

Jordi Miró, director of the ALGOS research group and of the Chair in Childhood Pain at the Universitat Rovira i Virgili (URV), has been appointed president of the Scientific Committee of the World Congress on Pain organised by the International Association for the Study of Pain (IASP) and scheduled for 2028 in a European city, which will be confirmed at the next IASP World Congress in Bangkok in 2026.

With more than 5,000 scientists and clinicians from around the world, the IASP World Congress is the most important international meeting to advance pain research and treatment. The appointment, announced in June 2025, recognises Miró’s career as a leading researcher in paediatric pain and highlights his contribution to the international projection of research in this field at the URV.

Jordi Miró is also the coordinator of the Spanish Network on Childhood Pain (funded by the Spanish Ministry of Economy, Industry and Competitiveness) and the International Network on Pain in Childhood (funded by the European Union’s ERA-NET Neuron programme) and has received several national awards for his work in this field, such as the 2013 and 2020 ICREA-Acadèmia awards, and international awards, such as the Fidel Ilizástigui Dupuy award for outstanding contributions to the development of medical sciences in Cuba. In recent years he became the IASP’s first Spanish councillor in the more than half a century that it has been in existence and is currently the organisation’s official representative in the Latin American region.

“This appointment is a great honour and a great responsibility for me. I hope to bring to the challenge an applied and rigorous approach to that reinforces the importance of involving all players in this field, including those from outside the anglophone world, which has traditionally dominated these events”, stated Jordi Miró, whose main objective is to “promote a plural view that allows us to advance knowledge and improve access to treatment for all people who suffer from pain”.

Through this appointment, the URV confirms its position as a leading university in the international study and treatment of pain and, in particular, child pain.